Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells

Peter E FECCI; Alison E SWEENEY; John H SAMPSON; Peter M GROSSI; Smita K NAIR; Christopher A LEARN; Duane A MITCHELL; XIUYU XIUYU CUI; Thomas J CUMMINGS; Darell D BIGNER; Eli GILBOA

doi:10.1158/1078-0432.CCR-06-0053

Back

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells

Journal article

Open access

Peer reviewed

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells

Peter E FECCI, Alison E SWEENEY, John H SAMPSON, Peter M GROSSI, Smita K NAIR, Christopher A LEARN, Duane A MITCHELL, XIUYU XIUYU CUI, Thomas J CUMMINGS, Darell D BIGNER, …

Clinical cancer research, Vol.12(14), pp.4294-4305

2006

DOI: https://doi.org/10.1158/1078-0432.CCR-06-0053

PMID: 16857805

Abstract

Neurology

Biological and medical sciences

Medical sciences

Tumors of the nervous system. Phacomatoses

Antineoplastic agents

Pharmacology. Drug treatments

Files and links (1)

url

https://doi.org/10.1158/1078-0432.CCR-06-0053View

Published (Version of record) Open

Metrics

10 Record Views

129 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.487 FOXP3
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells
Creators: Peter E FECCI - Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States
Alison E SWEENEY - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
John H SAMPSON - Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States
Peter M GROSSI - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
Smita K NAIR - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
Christopher A LEARN - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
Duane A MITCHELL - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
XIUYU XIUYU CUI - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
Thomas J CUMMINGS - Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States
Darell D BIGNER - Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States
Eli GILBOA - Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States
Publication Details: Clinical cancer research, Vol.12(14), pp.4294-4305
Publisher: American Association for Cancer Research; Philadelphia, PA
Academic Unit: Miller School of Medicine; Microbiology and Immunology Research
Language: English
Resource Type: Journal article
PMID: 16857805
Record Identifier: 991031559635202976